Focused on women’s health, the company has developed and commercialized prescription therapies addressing menopause and related conditions, including hormone replacement treatments. Its portfolio has included products such as Bijuva and Imvexxy, with commercialization and licensing arrangements shap...
1 member of Congress has disclosed 2 trades in TherapeuticsMD (TXMD), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 1 sale. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-12-21 | James Comer | sell | $1K – $15K |
| 2017-09-15 | James Comer | buy | $1K – $15K |